An Open-Label, Randomized, Parallel-Group Study of Bendamustine Hydrochloride and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Predmisone (R-CVP)

Grants and Contracts Details

StatusFinished
Effective start/end date1/13/10 → 6/30/18

Funding

  • Cephalon Inc: $106,422.00